Immunohistochemical expression of budding uninhibited by benzimidazole related 1 in leukoplakia and oral squamous cell carcinoma

Background: Budding uninhibited by benzimidazole related 1 (BUBR1) is an important protein in the mitotic spindle assembly checkpoint. Alterations in expression of BUBR1 have been reported in many premalignant and malignant lesions. Aim: To compare the expression of BUBR1 with respect to the normal mucosa and degree of dysplasia in oral leukoplakia (OL) and also with respect to different histopathological grades of oral squamous cell carcinoma (OSCC). Materials and Methods: Neutral buffered formalin-fixed and paraffin-embedded biopsy specimens 30 each of normal, OL and OSCC tissue were included in this study. The expression of BUBR1 was detected using immunohistochemistry (IHC). The scores obtained were subjected to ANOVA test. Results: Significant correlation was found in immunostaining between normal, dysplasia and OSCC groups with a P value of 0.00001. The expression of BUBR1 was significant when compared with different degrees of dysplasia and in different histopathological grades of OSCC with a P value of 0.00001. Conclusion: Higher IHC scores were obtained with increased histopathological grades of OL and OSCC suggesting its role as a prognostic indicator.

[1]  S. Elowe,et al.  Bub1 and BubR1: at the Interface between Chromosome Attachment and the Spindle Checkpoint , 2011, Molecular and Cellular Biology.

[2]  V. Canzonieri,et al.  BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival , 2011, Head & neck.

[3]  T. Blundell,et al.  BUB1 and BUBR1: multifaceted kinases of the cell cycle , 2011, Trends in biochemical sciences.

[4]  E. Donadi,et al.  BUBR1 expression in benign oral lesions and squamous cell carcinomas: correlation with human papillomavirus. , 2010, Oncology reports.

[5]  Jan-Gowth Chang,et al.  Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma. , 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[6]  R. Karess,et al.  BubR1- and Polo-Coated DNA Tethers Facilitate Poleward Segregation of Acentric Chromatids , 2010, Cell.

[7]  M. Yekezare,et al.  Escaping the firing squad: acetylation of BubR1 protects it from degradation in checkpoint cells , 2009, The EMBO journal.

[8]  N. Park,et al.  BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers , 2009, British Journal of Cancer.

[9]  H. Sugita,et al.  BubR1 and AURKB overexpression are associated with a favorable prognosis in gastric cancer. , 2009, Molecular medicine reports.

[10]  K. Hardwick,et al.  Bub1 Is a Fission Yeast Kinetochore Scaffold Protein, and Is Sufficient to Recruit other Spindle Checkpoint Proteins to Ectopic Sites on Chromosomes , 2007, PloS one.

[11]  B. Weaver,et al.  Aneuploidy: instigator and inhibitor of tumorigenesis. , 2007, Cancer research.

[12]  D. Baker,et al.  Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis , 2007, The Journal of cell biology.

[13]  Sook-Jung Jeong,et al.  Differential promoter methylation may be a key molecular mechanism in regulating BubR1 expression in cancer cells , 2007, Experimental & Molecular Medicine.

[14]  Hideyasu Matsuyama,et al.  Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. , 2007, Cancer genetics and cytogenetics.

[15]  O. Clausen,et al.  Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis , 2006, Journal of Clinical Pathology.

[16]  Z. Darżynkiewicz,et al.  BUBR1 deficiency results in abnormal megakaryopoiesis. , 2003, Blood.

[17]  K. Sullivan,et al.  Centromeres and Kinetochores From Epigenetics to Mitotic Checkpoint Signaling , 2003, Cell.

[18]  W. Dai,et al.  BUBR1 phosphorylation is regulated during mitotic checkpoint activation. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[19]  Stephen S. Taylor,et al.  The Human Homologue of Bub3 Is Required for Kinetochore Localization of Bub1 and a Mad3/Bub1-related Protein Kinase , 1998, The Journal of cell biology.

[20]  Zarin Zainul.  Recent Immunohistochemical Approaches for Predicting Tumor Recurrence in Oral Squamous Cell Carcinoma (OSCC) : Actors Beyond the Scene , 2012 .

[21]  M. Shichiri,et al.  Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. , 2002, Cancer research.